A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF 14-DAY INHALED TPI ASM8 IN SUBJECTS WITH ASTHMA

To determine the efficacy and safety of multiple inhaled daily doses of TPI ASM8 in steroid-naïve asthmatic adults with atopy

Kusajili – Clinical trials directory